Results 31 to 40 of about 3,384 (184)

Anticancer effects of punicalagin and 5-fluorouracil on laryngeal squamous cell carcinoma: an in vitro study

open access: yesItalian Journal of Medicine
The purpose of this study was to assess the apoptotic effects of punicalagin alone and in combination with 5-fluorouracil (5-FU) on laryngeal squamous cell carcinoma (Hep-2) cell line.
Amany M. Taha   +9 more
doaj   +3 more sources

Effects of Adding Punicalagin or Oleuropein to TRIS Diluent on Quality of Frozen–Thawed Semen from Rams [PDF]

open access: yesAnimals
This study aimed to investigate the effects of adding different levels of punicalagin or oleuropein to TRIS diluent on the quality of frozen–thawed semen from Najdi rams.
Mohamed Shehab-El-Deen   +6 more
doaj   +2 more sources

Preliminary screening of pomegranate-derived compounds for antimicrobial and anti-virulence effects against cariogenic streptococci [PDF]

open access: yesSaudi Dental Journal
As a biofilm-mediated disease, dental caries is primarily attributed to the activity of Streptococcus mutans and Streptococcus sobrinus, key contributors to enamel mineral loss under acidic conditions.
Nurhayati Mohamad Zain   +3 more
doaj   +2 more sources

Punicalagin in Cancer Prevention—Via Signaling Pathways Targeting [PDF]

open access: yesNutrients, 2021
The extract of pomegranate (Punica granatum) has been applied in medicine since ancient times due to its broad-spectrum health-beneficial properties. It is a rich source of hydrolyzable tannins and anthocyanins, exhibiting strong antioxidative, anti-inflammatory, and antineoplastic properties.
Izabela Berdowska   +2 more
openaire   +3 more sources

Punicalagin promotes autophagic degradation of human papillomavirus E6 and E7 proteins in cervical cancer through the ROS-JNK-BCL2 pathway

open access: yesTranslational Oncology, 2022
Punicalagin, which is derived from pomegranate peel, is reported to exert growth-inhibitory effects against various cancers. However, the underlying mechanisms have not been elucidated.
Xialin Xie   +9 more
doaj   +1 more source

Punicalagin Damages the Membrane of Salmonella Typhimurium

open access: yesJournal of Food Protection, 2020
Salmonella, a bacterial foodborne pathogen, can contaminate meat, milk, and vegetables. While appropriate measures are available to control Salmonella, the inhibitory phytochemicals from plants are gaining increased attention. Punicalagin, a natural antimicrobial, is one of the main active tannins isolated from Punica granatum L.
Guanghui Li   +3 more
openaire   +2 more sources

Quantification of punicalagin in pomegranate peels from high-performance thin-layer chromatography

open access: yesBiomedical and Biotechnology Research Journal, 2022
Background: Punicalagin is the main phenolic compound present in pomegranate (Punica granatum), it possesses various kinds of activities which is very essential as a dietary supplement, herbal supplements, or nutraceuticals are widely available in the ...
Pooja Gadkari, Sanjay J Daharwal
doaj   +1 more source

Determination of Ellagic Acid, Punicalagin, and Castalagin from Terminalia ferdinandiana (Kakadu plum) by a Validated UHPLC-PDA-MS/MS Methodology

open access: yes, 2021
Punicalagin, a bioactive ellagitannin predominantly found in Pomegranate, has a wide range of health benefits including potent antioxidant properties. The metabolism of punicalagin in human body produces urolithins and ellagic acid.
Akter, Saleha   +6 more
core   +1 more source

Inhibitory Effect of Punicalagin on Inflammatory and Angiogenic Activation of Human Umbilical Vein Endothelial Cells

open access: yesFrontiers in Pharmacology, 2021
Punicalagin, a major ellagitannin isolated from pomegranate, is proved to have various pharmacological activities with an undefined therapy mechanism. The objective of this research was to demonstrate the effect of punicalagin on anti-inflammatory and ...
Wei Liu   +8 more
doaj   +1 more source

Punicalagin Ameliorates Lupus Nephritis via Inhibition of PAR2 [PDF]

open access: yesInternational Journal of Molecular Sciences, 2020
Lupus nephritis (LN) is the most frequent phenotype in patients with systemic lupus erythematosus (SLE) and has a high rate of progression to end-stage renal disease, in spite of intensive treatment and maintenance therapies. Recent evidence suggests that protease-activated receptor-2 (PAR2) is a therapeutic target for glomerulonephritis. In this study,
Yohan Seo   +10 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy